e-therapeutics plc (LON:ETX – Get Rating) shares passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 18.89 ($0.23) and traded as low as GBX 16.25 ($0.20). e-therapeutics shares last traded at GBX 16.75 ($0.20), with a volume of 922 shares.
e-therapeutics Trading Up 3.6 %
The stock’s fifty day simple moving average is GBX 18.61 and its two-hundred day simple moving average is GBX 18.89. The firm has a market cap of £97.50 million and a PE ratio of -9.85. The company has a quick ratio of 20.13, a current ratio of 22.64 and a debt-to-equity ratio of 2.03.
Insider Buying and Selling
In related news, insider Trevor Mervyn Jones bought 44,350 shares of the company’s stock in a transaction on Wednesday, January 4th. The shares were acquired at an average cost of GBX 17 ($0.21) per share, with a total value of £7,539.50 ($9,200.12).
e-therapeutics Company Profile
e-Therapeutics plc engages in drug discovery research activities in the United Kingdom. Its computational platform provides in silico screens generate predictions on compounds and/or targets that can have a significant perturbative effect on the biology of interest, captured by its network models, as well as developing RNAi platform for highly specific gene silencing.
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving ’23 Growth
Receive News & Ratings for e-therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for e-therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.